Achieve Life Sciencesincis A Specialty Pharmaceutical Company Focused On Combating Smoking Related Health Issues And Nicotine Addictionthe Company Is Dedicated To The Development And Commercialization Of Cytisiniclinea Plant Based Alkaloid Designed To Assist With Smoking Cessation And Reduce Nicotine Withdrawal Symptoms In Addition To Its Primary Productachieve Life Sciences Engages In Clinical Stage Research To Enhance The Effectiveness Of Cytisinicline For Treating Nicotine Addictionthe Company Has Established Partnershipsincluding A License And Supply Agreement With Sopharma Ad And The University Of Bristolachieve Life Sciences Operates In The Healthcare Sectorspecifically Within The Biotechnology Industryand Is Listed On The Nasdaq Under The Ticker Symbol Achvthe Company Has Headquarters In Bothellwashingtonand Vancouvercanadaand Is Led By Ceo Richard Astewart
